Table 5 Clinical predictors of outcome in the studied subjects (continued)
From: Predictive factors of epilepsy outcome in a sample of Egyptian pre-elderly and elderly population
Variables | Good outcome | Poor outcome | P value | |
|---|---|---|---|---|
Status epilepticus (%) | 5.19% | 52.17% | < 0.001* | |
Seizure precipitants (%) | No precipitants | 36.36% | 30.43% | 0.103 |
Stress | 33.77% | 21.74% | ||
Sleep | 12.99% | 8.70% | ||
Sleep deprivation | 10.39% | 21.74% | ||
Anti-epileptic drugs (%) | Carbamazepine | 42.86% | 43.48% | 0.958 |
Valproate | 41.56% | 30.43% | 0.337 | |
Phenytoin | 11.69% | 21.74% | 0.223 | |
Levetiracetam | 28.57% | 47.83% | 0.085 | |
MRI brain findings (%) | Normal | 64.94% | 26.09% | 0.005* |
Encephalomalacia | 24.68% | 47.83% | ||
Temporal atrophy | 3.90% | 17.39% | ||
EEG changes (%) | Normal | 66.23% | 17.39% | < 0.001* |
Focal changes | 29.87% | 60.87% | ||
Generalized changes | 5.19% | 26.09% | ||